Epidemiology, Temporal and Seasonal Trends, and Geographic Distribution of Leptospirosis in the Dominican Republic, 2012 to 2026
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Leptospirosis is a widespread zoonotic infection and a growing public health concern in tropical, resource-limited settings, yet remains underrecognized and underreported where diagnostic and surveillance infrastructure is limited. We conducted an analytical cross-sectional study of national surveillance data from the Dominican Republic (2012-June 2026), integrating geospatial meteorological data to characterize disease burden, trends, seasonality, and clinical risk factors. Of 8,425 records, 5,412 met case-definition criteria (3,441 suspected, 1,448 probable, 523 confirmed), yielding a cumulative incidence of 3.55 per 100,000 person-years (2012-2025). Laboratory confirmation rose markedly, from 9.7% overall to half of 2025 cases and over half in 2026. Overall incidence remained stable across all years (p = 0.15), though with three distinct periods: declining infection pre-COVID, low infection during COVID, and increasing infection post-COVID. Cases clustered in the rainy/hurricane season (61.1%, May-November; p< 0.001), with a marginal rainfall correlation (r= 0.553, p= 0.062). Rural provinces bore disproportionate risk, led by Hermanas Mirabal (16.43/100,000 person-years), while large urban and coastal provinces had rates 80% lower. Men had 2.73-fold higher incidence than women (95% CI 2.56-2.90), peaking at younger ages 10-29. Comorbidity was the strongest predictor of complications (OR 2.84, 95% CI 2.01-4.02, p< 0.001). Limited diagnostic confirmation remains the central obstacle to characterizing leptospirosis burden in the Dominican Republic, with confirmation rates exceeding 40% only from 2023 onward. This first multi-decade national analysis identifies high-risk provinces, demographic groups, and seasonal windows for targeted surveillance, highlighting expanded diagnostic capacity as a priority for burden estimation and case management.